3+ day, 15+ hour ago   (179+ words) SAO PAULO, Sept 10 (Reuters) – Brazilian Senator Flavio Bolsonaro and President Luiz Inacio Lula da Silva ​are statistically tied in a ‌simulated runoff ahead of next month’s election, an AtlasIntel/Bloomberg poll showed on Thursday, with the right-wing lawmaker now holding…...

3+ day, 19+ hour ago   (526+ words) By Oliver Hirt and Marleen Kaesebier ZURICH, Sept 10 (Reuters) – A major shareholder in Novartis has called for a shake-up of the Swiss drugmaker’s board to improve corporate governance after its shares suffered a record fall this week following back-to-back trial…...

4+ day, 17+ min ago   (565+ words) Sept 10 (Reuters) – Sweden will hold a parliamentary election on September 13 with the centre-left opposition holding a slim lead in opinion polls over Prime Minister Ulf Kristersson’s ruling right-wing bloc. Kristersson is seeking to form a majority government with his existing…...

4+ day, 16+ hour ago   (58+ words) whbl.com Republican lawmakers criticize Ford business ties to China WASHINGTON, Sept 9 (Reuters) – Republicans in Congress on Wednesday ​joined criticism of Ford Motor over its business ties to Chinese firms after ​Transportation ⁠Secretary Sean Duffy ⁠sharply criticized the No. 2 U....

4+ day, 19+ hour ago   (560+ words) VENICE, Sept 9 (Reuters) – A film shot when war between Russia and Ukraine seemed unthinkable finally hit Venice on Wednesday, with director Ilya Khrzhanovsky unveiling “DAU”, a 20-year project that has generated both fascination and controversy. Ukraine’s government has objected to…...

4+ day, 21+ hour ago   (237+ words) BEIJING, Sept 9 (Reuters) – Tencent-backed AI chipmaker Shanghai Enflame Technology will make its Shanghai stock market debut on September 11, an ​exchange filing showed on Wednesday. Enflame, one ‌of China’s leading AI chip startups known locally as the “four little GPU dragons…...

5+ day, 16+ hour ago   (317+ words) Sept 8 (Reuters) – Shares of Dyne Therapeutics and Sarepta slumped on Tuesday after Novartis’ treatment for a muscle-wasting disorder failed in a trial, fueling investor concerns ​about the prospects of similar therapies for the tough-to-treat ‌rare disease. Dyne’s stock led declines…...

5+ day, 22+ hour ago   (257+ words) Sept 8 (Reuters) – Bristol Myers Squibb said on Tuesday its experimental cell therapy showed a high overall response rate in a mid-stage trial, ​in patients with a hard-to-treat form of ‌blood cancer. The study evaluated the therapy, called arlocabtagene autoleucel, or…...

6+ day, 5+ hour ago   (652+ words) NEW DELHI, Sept 8 (Reuters) – India is witnessing an unprecedented food safety crackdown, with regulators forcing many local eateries and branded restaurants to suspend operations, while a push for front-of-pack warning labels has rattled the country’s more than $100 billion packaged food…...

1+ week, 2+ day ago   (464+ words) By Christy Santhosh and Bhanvi Satija Sept 4 (Reuters) – Novartis said on Friday its experimental drug pelacarsen did not cut the risk of major heart attacks and strokes in patients with a genetic risk factor in a late-stage trial, marking a…...